PTX 5.26% 4.0¢ prescient therapeutics limited

One year from now, page-2

  1. 231 Posts.
    lightbulb Created with Sketch. 10
    Not knowledgeable, but I am happy to get the ball rolling with one measurable outcome
    For personal reasons, I would like to see:
    - a 2 or 3 antigen multi-centre Australian GBM clinical trial underway with Omnicar, using Cellpryme M, Cellpryme A, and utilising that 2-3 week post-infusion rest period like Kevin described. I think such a trial will seriously move the dial with GBM.




 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.002(5.26%)
Mkt cap ! $32.21M
Open High Low Value Volume
3.9¢ 4.2¢ 3.8¢ $64.33K 1.650M

Buyers (Bids)

No. Vol. Price($)
1 25000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 35499 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.